I just had a look at our 2018 financial report.
SPD ( specialty brands )
Revenue $98m
GP. $79.8 m
This past year $59 m. Profit.
A 25% reduction in profit in our new
improved Segment from 3 years ago.
How does the CEO talk about the vast
improvements he has achieved and sound
so convincing. What about our infectious
disease specialty area. Tolsura etc. Are they
no longer specialising in that area? This
guy keeps preaching to the recently joined
shareholders. Please somebody remove
the Charlatan .
MYX CHART, page-376
-
- There are more pages in this discussion • 162 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.34 |
Change
0.080(1.88%) |
Mkt cap ! $369.2M | |||
| Open | High | Low | Value | Volume |
| $4.27 | $4.35 | $4.25 | $408.4K | 94.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1900 | $4.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.35 | 579 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |